Advertisement

August 7, 2019

Boston Scientific Will Distribute Endologix Products in China

August 8, 2019—Endologix, Inc. announced an agreement naming Boston Scientific Corporation as the exclusive distributor for Endologix products in China. The long-term agreement includes distribution rights to the company's current endovascular aneurysm repair and endovascular aneurysm sealing products, as well as the right of first negotiation for future product offerings by Endologix.

As part of the agreement, Boston Scientific plans to invest in building a dedicated sales team to commercialize the Endologix products and drive adoption in China. Additionally, Endologix will provide commercial and clinical support and training to the Boston Scientific team. Boston Scientific expects to begin selling these products upon local regulatory approval and subsequent commercial launch of the first product, anticipated in 2021.

The current portfolio of Endologix products includes the Ovation abdominal stent graft and the AFX2 endovascular abdominal aortic aneurysm system. Both of these devices have received FDA clearance in the United States and CE Mark approval in Europe, noted the company.

Advertisement


August 8, 2019

Siemens Healthineers to Acquire Corindus Vascular Robotics

August 8, 2019

Siemens Healthineers to Acquire Corindus Vascular Robotics